retatrutide triple agonist glp-1 gip glucagon ly3437943 🧬Retatrutide (LY3437943) — The Triple-Agonist Powerhouse activates GLP-1, GIP, and receptors simultaneously, setting it apart from single or dual-action drugs like semaglutide and tirzepatide. 📊 Clinical Data — All Phases GLP-3 (R) - Triple GIP

It supports the formation of myelin, the protective sheath around nerves, which helps transmit electrical impulses efficiently

Two types of medications for ulcers and gastric reflux proton-pump inhibitors, such as omeprazole (Prilosec) and lansoprazole (Prevacid), and H2 blockers like cimetidine (Tagamet), famotidine (Pepcid), and ranitidine (Zantac) inhibit the release of stomach acid necessary to free dietary vitamin B12

Diabetes 62, 23802385

The results show that DPP-4 inhibition reduces HbA1c in these patients and that the treatment is well-tolerated with similar rate of adverse events as placebo

Alcohol enables the accumulation of ROS, thus affecting the body defense mechanisms against these products, mainly in the liver

& MacFabe, D